Publication | Closed Access

Soluble PD-L1 with PD-1-binding capacity exists in the plasma of patients with non-small cell lung cancer

Cancer ImmunosurveillanceMedicineImmunologyPd-1-binding CapacityBronchial NeoplasmImmune Checkpoint InhibitorLung CancerOncologyRadiation OncologyTumor MicroenvironmentCancer Research